D N (Israel) Financial Indicators Patterns

DNA -- Israel Stock  

ILS 26.30  0.10  0.38%

Use fundamental data analysis to check all available reported financial drivers of D N A to find out if markets are at this moment mispricing the company. We found twenty-three available fundamental indicators for D N A Biomedical Solutions Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all D N A fundamentals including its Cash and Equivalents, Beta, Current Liabilities, as well as the relationship between Cash Flow from Operations and Retained Earnings . Use D N to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of D N to be traded at S26.04 in 30 days.

Chance of Financial Distress

D N A Biomedical Solutions Ltd has more than 89 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

D N Company Summary

D N competes with Compugen Ltd, Kamada Ltd, Pluristem Therapeutics, BioLine Rx, and Evogene Ltd. D.N.A Biomedical Solutions Ltd. develops and commercializes laser spectrometry-based trace detection systems in Israel. D.N.A Biomedical Solutions Ltd. was founded in 2004 and is based in Ramat Gan, Israel. D N operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.

D N Price to Earning vs Current Ratio

D N A Biomedical Solutions Ltd is rated # 2 in price to earning category among related companies. It is rated below average in current ratio category among related companies . The ratio of Price to Earning to Current Ratio for D N A Biomedical Solutions Ltd is about  753.00 

D N A Systematic Risk

The output start index for this execution was twenty-four with a total number of output elements of fifteen. The Beta measures systematic risk based on how returns on D N A correlated with the market. If Beta is less than 0 D N generally moves in the opposite direction as compared to the market. If D N Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one D N A is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of D N is generally in the same direction as the market. If Beta > 1 D N moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

D N April 20, 2019 Opportunity Range

Additionally see Investing Opportunities. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Search macroaxis.com